Company
Via Nova Therapeutics
Advancing the next generation of antiviral therapies
Also known as Via Nova Therapeutics, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Founded
- 2021
- Legal name
- Via Nova Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
At Via Nova Therapeutics, our mission is to discover novel therapies for viral diseases, especially those arising from acute and subacute infections, and to efficiently bring these treatments to the clinic.
Funding snapshot
- Total raised
- $5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5M2021-08-31
Funding rounds
- Round, 2021
- $5M2021-08-31, SEC form D sold, 2 investors
Products
- Other
- VNT-101
Loading relationship preview